Gene · 7114
Papers2,131
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,131
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Craniofacial Involvement Is Associated With Poor Prognosis in Extranodal Diffuse Large B-Cell Lymphoma. | Hematol Oncol | 2026 | 42781756 | PubTator, text mining | PubMed |
| Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling. | Mol Biomed | 2026 | 42606759 | PubTator, text mining | PubMed |
| Peptide Supplements and Their Therapeutic Applications in Sports Medicine. | Am J Sports Med | 2026 | 42578445 | PubTator, text mining | PubMed |
| [TMSB4X Promotes Proliferation and Metastasis of T-cell Acute Lymphoblastic Leukemia Cells by Regulating the Wnt/β-catenin Signaling Pathway]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544648 | PubTator, text mining | PubMed |
| Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial. | EBioMedicine | 2026 | 42531722 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis reveals spatial features in human Stanford type A aortic dissection. | iScience | 2026 | 42519065 | PubTator, text mining | PubMed |
| Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome. | Front Immunol | 2026 | 42440461 | PubTator, text mining | PubMed |
| PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo. | Bioeng Transl Med | 2026 | 42394899 | PubTator, text mining | PubMed |
| Sprayable bioadhesive microcarriers loaded with Tβ4-Engineered ADSC exosomes for diabetic wound healing. | Bioact Mater | 2026 | 42383202 | PubTator, text mining | PubMed |
| Longitudinal Trends of Salivary Oxidized Thymosin β4 and β10 in Preterm Infants with Bronchopulmonary Dysplasia. | Children (Basel) | 2026 | 42353940 | PubTator, text mining | PubMed |
| Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses. | Biomolecules | 2026 | 42352234 | PubTator, text mining | PubMed |
| A novel lactylation-related gene signature deciphers the immunosuppressive microenvironment and stratifies precision therapy in colorectal cancer. | Discov Oncol | 2026 | 42342961 | PubTator, text mining | PubMed |
| Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS. | J Neuroinflammation | 2026 | 42237169 | PubTator, text mining | PubMed |
| Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation. | Integr Med (Encinitas) | 2026 | 42222211 | PubTator, text mining | PubMed |
| The implications of TMSB4X in TIM3 hypermethylation and CD8+ T cell exhaustion in diffuse large B-cell lymphoma. | Sci Rep | 2026 | 42177276 | PubTator, text mining | PubMed |
| Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. | Sports Med | 2026 | 41966639 | PubTator, text mining | PubMed |
| DNase I as a probe for unpolymerized actin: revisiting a classic tool for nuclear actin research. | Pflugers Arch | 2026 | 41882381 | PubTator, text mining | PubMed |
| Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers (Review). | Oncol Rep | 2026 | 41860034 | PubTator, text mining | PubMed |
| Emerging Biologics in Lumbar Disc Degeneration: PRP, Stem Cell Therapy, and Pharmacotherapy in Mobility Restoration and Rehabilitation. | J Spine Res Surg | 2026 | 41852545 | PubTator, text mining | PubMed |
| Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma. | Hematol Oncol | 2026 | 41852166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7114/papers